Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neurones S.A. Earnings Release 2012

Feb 6, 2013

1548_iss_2013-02-06_5b0996ea-d3b5-432c-b797-55d0fea62c84.pdf

Earnings Release

Open in viewer

Opens in your device viewer

PRESS INFORMATION Nanterre, February 6, 2013 (after the closing of the stock exchange)

Heading: 2012 annual revenues

2012 annual revenues up 11.3% to €315.4 million

Revenues
(millions of euros)
2012 2011 growth
Annual 315.4 283.3 + 11.3%
4th quarter 84.6 76.4 + 10.7%

Achievements

For 2012, organic growth stands at + 9.3% in a consulting and IT services market that was expected to be stable in 2012.

In the 4th quarter, NEURONES' organic growth totaled + 8.3% (after + 11.0% in Q3, + 3.7% in Q2 and + 15% in Q1). This was the 35th consecutive quarter of organic growth.

Operating profit (*) in 2012 totaled 8.9% of revenues.

During the year, net cash and cash equivalents (no financial debt) increased from €75.1 to €87.8 million.

There were over 3,700 people on staff at the end of 2012.

The final annual results will be published on Wednesday, February 27, 2013 after the stock exchange closes.

(*) after 0.4% related to the cost of free shares, stock options and impairment of assets.

Outlook

As usual, forecasts for the coming year will be published along with the Group's 1st quarter revenues for 2013.

About NEURONES

With over 3,700 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years.

NYSE Euronext: Compartment B – ISIN code: FR0004050250 – NYSE symbol: NRO www.neurones.net

Press Relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 [email protected]

NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 [email protected]

Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 [email protected]

CONSULTING ▪ INTEGRATION ▪ OUTSOURCING

Immeuble "Le Clemenceau 1" - 205, avenue Georges Clemenceau - F-92024 Nanterre Cedex Tel.: +33 (0)1 41 37 41 37 - Fax: +33 (0)1 47 24 40 46 - e-mail: [email protected] - www.neurones.net Societe Anonyme au Capital de 9,503,8653.60 € - R.C.S. NANTERRE B 331 408 336 - Code TVA FR 46331408336 - Siret 331 408 336 00021 – APE 6202A